① Today, “selling blood” 16 times in 8 months? A 19-year-old died suddenly!” The news became a hit, and the father of the deceased's statement that “the interval between blood collection is less than 12 days” attracted attention; ② Tiantan Biotech announcement responded that “the shortest interval between pulp donation days mentioned in the report is 12 days is false information,” and industry insiders said the 14-day interval was a “red line.”
Financial Services Association, March 20 (Reporter Lu Afeng) Today, “selling blood” 16 times in 8 months? A 19-year-old died suddenly!” The media report became popular on social platforms, questioning that Xinzhou Tiantan Biotech Single Plasma Collection Co., Ltd., which belongs to Tiantan Biology (600161.SH), collected the person concerned 16 times within 8 months through a “connector”.
The report quoted the father of the deceased as saying that the shortest time between pulp collection was 12 days, causing the person concerned to have severe anemia and suspected hematopoietic dysfunction.
In the afternoon, Tiantan Biotech issued an announcement in response to the incident: “The shortest time between plasma donation days mentioned in the report is 12 days. The Xinzhou Plasma Station strictly complies with relevant regulations to ensure that plasma donors donate no less than 14 days between two plasma donations. At the same time, after checking basic information such as the age of the plasma donor and the relevant medical examination data at the time of plasma donation, the conditions met the requirements for plasma collection.”
The National Health Commission's “Administrative Measures on Single Plasma Collection Stations” stipulates that the time interval between two plasma donations shall not be less than 14 days. A number of plasma product listed company insiders told the Financial Federation that the interval between plasma collection is a “red line” of no less than 14 days. Regular plasma stations will strictly abide by it, but when it comes to individual cases, the official investigation findings should prevail.
On the evening of March 19, the Health and Sports Bureau of Xinfu District, Xinzhou City, Shanxi Province issued an information notice stating that it had taken note of the relevant online reports. The Xinfu District Committee and District Government attached great importance to this and immediately set up a special investigation and disposal work class composed of district committee and district government leaders, the District Health and Sports Bureau, the District Commission for Discipline Inspection and Supervision Commission, and the branch directly under the Xinzhou Public Security Bureau to investigate reports on the Internet. At present, the investigation has been fully carried out, and the relevant information will be promptly announced to the public.
According to the Tianyancha App, the Xinzhou Tiantan Biological Single Plasma Collection Co., Ltd. was established in 2007 with a registered capital of 20 million yuan and a staff size of less than 50 people. The scope of business is single plasma collection (preparation and collection of human plasma used in the production of blood products and hepatitis B-specific immune plasma) within the approved area of the single collection license. Chengdu Rongsheng Pharmaceutical Co., Ltd. controls 80% of the blood station's shares, while Tiantan Biotech holds Chengdu Rongsheng Pharmaceutical Co., Ltd., which belongs to Tiantan Biotech's Sun Company.
The reporter tried to call the deceased's father to learn more about the situation, but was unable to get in touch at the time of press release.